Skip to content

WHO removes Cipla AZT, 3TC products from prequalification list

Study finds that 8% of newly diagnosed HIV patients in US have drug resistance

Hepatatis B can flare up even during lamivudine treatment in HIV-positives

Breastfeeding and HIV: need to target postnatal treatment to mothers with advanced HIV?

Tipranavir access expanded, but doctors warned on double boosted PI regimens

HAART is effective in prisoners, but benefit may be lost upon release

Abbott receives warning from FDA over ritonavir price claims

Early treatment with a four-drug combination a good option for HIV-infected infants

Double-boosted saquinavir/atazanavir study lays ground for PI-only regimen